Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-24 @ 10:06 PM
NCT ID:
NCT03539835
Eligibility Criteria:
Inclusion Criteria:
1. within 6 months to 10 years post active breast cancer therapy (i.e. surgery/chemotherapy) for stage I-III invasive breast cancer,
2. at least 6 months post breast reconstruction (if applicable),
3. lack of menses for at least one year,
4. BMI 20-35 kg/m2,
5. fatigued (subjective reporting ≥3 on a 1-10 scale),
6. untrained with regard to structured resistance training (no more than 3x/week).
Exclusion Criteria:
1. plans for surgery (e.g., breast reconstruction) during the study period,
2. taking an anticoagulant medication (i.e. heparin, apixaban, rivaroxaban),
3. allergic to lidocaine,
4. orthopedic or chronic pain condition restricting exercise,
5. Mini-Mental Status Examination (MMSE) scores below education-specific cut-points (less than 23 for more than 9th grade education and less than 17 for less than 8th grade education),
6. unable to receive physician medical clearance.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
50 Years
Maximum Age:
75 Years
Study:
NCT03539835
Study Brief:
Protocol Section:
NCT03539835